Technical Analysis: Based on the latest data, MFC closed at $30.56 on January 24, 2025, with RSI(14) at 48.47, indicating a neutral momentum. The stock is trading above its 200-day moving average of $27.76, suggesting a long-term uptrend. The Fibonacci levels show key resistance at $30.95 and support at $29.65.
News Sentiment Analysis: Recent analyst coverage remains positive, with RBC Capital maintaining a Buy rating and setting a price target of C$49.00. The consensus among analysts is a Strong Buy with a price target of $33.87, indicating potential upside. However, insider sentiment is negative, with 148 insiders selling shares recently.
Price Prediction for Next Week: Based on technical indicators and news sentiment:
Expected price movement: The stock is likely to trade between $29.65 and $30.95, with a higher probability of testing the resistance level of $30.95 due to:
Target price: $30.90 by end of next week
Trading Recommendation: BUY at current levels ($30.56) with a stop loss at $29.65 (Fibonacci S1). The risk-reward ratio is favorable with potential upside of 1.1% to target and downside limited to 3% at stop loss.
The price of MFC is predicted to go up 4.8%, based on the high correlation periods with TRV. The similarity of these two price pattern on the periods is 96.23%.
MFC
TRV
Manulife could achieve strong growth in Asia within the next few years, driving overall top-line growth and improving geographic diversification.
Manulife has clearly laid out plans to reduce exposure to riskier products like long-term care insurance and variable annuities and increase exposure to high-potential businesses like behavioral insurance, asset management, and Asia.
The company will be a net beneficiary of rising interest rates in the long run as it can reinvest its maturing fixed-income securities at a higher yield.